Case Study
Monday, September 23
08:45 AM - 09:15 AM
Live in Berlin
Less Details
The presentation describes the introduction of the quality culture concept at Boehringer Ingelheim. The pharmaceutical industry is highly regulated in the area of quality in order to safeguard products and minimize risks. Since production in the pharmaceutical industry requires a high level of quality assurance, Boehringer Ingelheim has introduced a new approach in the form of a quality culture. In the session, you will learn:
• How to initiate a new approach to structure quality management
• How to involve all levels of the workforce for the right strategy
• How to increase the level of quality of products
• How to adapt processes to regulations
Ulrike Falks is Quality Head for all BioPharma Sites of Boehringer-Ingelheim in Europe, USA and China; Drug Substance and Drug Product; CMB and internal products as well as Combination Products; Launch and Innovation Quality, 3Party Quality Management and Quality Systems are also part of the network, embracing around 2000 colleagues worldwide